Respiratory tract infections Flashcards

1
Q
List the clinical terms to describe infection
of the 
- Nose
- Throat
- Sinuses
- Ear
- Epiglottis
- Larynx
A
  • Rhinitis
  • pharyngitis
  • sinusitis
  • ottitis
  • epiglottitis
  • laryngitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Distinguish between upper and lower resp tract infections

A

Lower- BELOW LARYNX- life threatening- viruses and bacteria
bronchitis, bronchiolitis, pneumonia
Upper- acute infection- viral- nose sinuses pharynx larynx, tonsilitis, pharyngitis, laryngitis, otitis, common cold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe causes of coryza (common cold) and effects

A
Adenoviruses
Rhinoviruses >1000 serotypes
Enteroviruses- coxsackie, echos (babies, kids)
Corona viruses eg SARS MERS
Respiratory syncytial viruses

can lead to secondary bacterial infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe causes of pharyngitis and tonsillitis and effects

A

Viruses (adenomas), EB virus, streptogene bacteria

white tonsils due to EB virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe epiglottitis

A

Bacterial, life threatening, swell–block airway

Haemophilus influenzae type b (now rare)- EFFECTIVE VACCINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe croup

A

Young children- inspiratory stridor- narrowed airways
Noisy expiration
due to viruses such as paraflu, RSV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the features and causative agents of infectious mononucleosis

A

Glandular fever is a syndrome not an aetiological diagnosis
Features- pharyngitis, lymphadenopathy (cervical, generalised), fever, malaise
Atypical mononuclear cells in periphery, activated Tc cells and CD8

Causes: EB virus
Cytomegalovirus
Toxoplasmosis (parasite)
HIV seroconversion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List viral causes of LRTIs

A
  • Influenza, resp syncytial virus
  • Rarely- varicella voster (adults)
  • Measles virus (giant cell pneumonia)
  • Cytomegalovirus (immunocompromised)
  • MERS (and SARS) coronaviruses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the features, symptoms, pathogenesis and complications of influenza virus

A

Features:

  • Segmented single stranded RNA genome (ssRNA)
  • 8 segments encode 11 proteins.
  • 4 haemaglutinic acid binds sialic acid on cells to initiate infection

Symptoms:

  • Respiratory tract symptoms e.g. rhinitis, cough, shortness of breath
  • Systemic symptoms e.g. fever, headaches, myalgia

Influenza- 3 types - A, B, C. A has subtypes

Pathogenesis

  • Pneumotropic- infects cells lining resp tract–down to alveoli
  • Is lytic- strips off resp epi- exoliate epi cells
  • Remove innate defence mechanisms- mucus and cilia
  • Interferon production – circulates in blood (virus doesn’t)

Complications
- In the respiratory tract – pneumonia – 2 types
- 1° viral pneumonia: mononuclear cell infiltrate
- 2° bacterial pneumonia: PMNL infiltrate
- Cardiovascular complications
myocarditis
- Central nervous system complications
Encephalitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe antigenic drift

A

Happens in A and B
random spontaneous mutation in viral genome
encode HA and NA- 1-2% AA sequence change
- Mutations clustered in HA and NA- Darwinian evolution- selected by host immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe antigenic shift

A

Genetic reassortment between human and non human virus- new subtypes
A
20% AA difference- new pandemic strains against pop which has no immunity
- Large % of pop infected in epidemic become immune, next epidemic 4-5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define the terms epidemic and pandemic

A

Epi- widespread occurence of influenza in community at a particular time
Pan- Epidemic spreads on worldwide scale and infects large proportion of pop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the clinical features of RSV

A

Causes LRTI in infants – bronchiolitis, pneumonia
• High hospitalisation rates
• Low mortality (<0.5%) unless
o Congenital heart disease
o Congenital lung disease (incl. prematurity)
o Immunodeficiency (congenital or acquired)

Requires rapid diagnosis and appropriate infection control measures
• Re-infection occurs throughout life - antigenic drift

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the diagnosis of community acquired pneumonia and groups in which it is more common

A

Pulmonary shadowing on CXR and new or existing LRTI symptoms

Males, elderly, chronic illness, alcoholics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the aetiology of CAP

A

60-80% caused by conventional bacteria

Atypical bacteria and viruses cause the rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List the bacteria that cause CAP

A

S, C, M pneumonia
L pneumophilia
H influenzae

17
Q

Outline S pneumonia

A

Most common in those without COPD
Major virulence factor- capsular polysac
Relative penicillin resistance

18
Q

Outline H influenzae

A

Common in kids who haven’t had HIB
Non capsulated
KEY CAUSE OF COPD

19
Q

Outline C pneumoniae

A

URTI in infancy, CAP in elderly

20
Q

Outline M pneumoniae

A

Second most common cause of CAP- mycoplasma
Mycoplasma causes > 40% of CAP in the 17 - 44 year old age group
Can cause epidemic
Extra pulmonary features
Treat with tetracyclines

21
Q

Outline L pneumophilia

A

Causes sporadic and outbreak CAP
Cause severe disease in immunocompromised and smokers
Serogroup 1 causes almost all human infection

22
Q

Outline hospital acquired pneumonia

A

Occurs 48 hours after hosp admission

E coli, klabsiella spp, proteus spp., S. pneumoniae, S. aureus (MSSA or MRSA)

23
Q

List the predisposing factors to recurrent lung infections

Outline organisms involved

A
  • Cystic fibrosis- chronic bac airway infection
    S aureus+ P aeruginosa
    Persistent/progressive symptoms-intermittent acute exacerbation
    treat- antimicrobials- 2-3wks
  • COPD- chronic bronchitis and emphysema
    Airways narrow
24
Q

Outline diagnosis of LRTIs

A

Confirm diagnosis, assess severity
Temp, full blood count, urea, electrolytes, LFTs CXRs, aBG/CBG
Microbial investigations- sputum, immunofluorescence of sputum, blood cultures, urinary legionella antigen

25
Q

Define aetiology/aetiological agents

A

Causative factor/factor that leads to an increased risk of acquiring a disease

26
Q

List the common causes of tuberculosis

A

HIV- greater susceptibility and developing countries

MYCOBACTERIUM TUBERCULOSIS
+ M bovis (TB in cattle), M africanum, M microti

Others:
M. kansasii: uncommon cause of respiratory infection
• M. avium-intracellulare: causes disseminated disease in AIDS patients
• M. marinum: uncommon cause of skin infections (‘fish-tank granuloma’)
• M. chelonei – rapid growing ‘environmental’ species: may contaminate
bronchoscopes!
• M. leprae: cause of Leprosy (cannot be grown in vitro)

27
Q

Describe the main pattern of lung infection by M tuberculosis

Describe spread

A
  • Obligate aerobes so go grow in high O2- lungs
  • Faculative intracellular pathogens- infect mononuclear phagocytes (macrophages)
  • Slow growing- 12-18 hours, hydrophobic, less perm to to bac stains
  • Known as acid fast bacilli- resist decolourisation when stained

Spread:

  • Airborne droplets- 1-5microm
  • Nuclei remain airborne after hours
  • Droplets inhaled- lodge in alveoli- taken up by (M)
  • Spread via lymph system- hilar lymph nodes
28
Q

Describe the features of tuberculosis

A

Cell mediated immunity 2-8 wks post infection- +ve tuberculin skin test
Activated t lymphocytes and macrophages form granulomas- limit further rep
Most individuals asymptomatic (latent infection) and never develop active disease.

29
Q

Describe the clinical presentation of TB

A

Non specific symtoms- pyrexia, wt loss, night sweats
Resp- cough, SOB, haemoptasis, chest pain

Mainly pulm disease/extrapulm in HIV

  • Most severe if CNS disease eg TB meningitis/SOL
  • Skin/soft tissue- cervical lymphadentis, diffuse neck swelling
  • Bone and joints- spine- Pott’s
  • GU- prostatis, orchitis, renal lesions, infertility in women
  • Diseminated disease- miliary pattern on CXR
30
Q

Describe diagnosis of TB

A

Sputum, bronchoalveolar lavage, pus/tissue, urine CSF
- ZN stain- rapid, cheap, simple, moderate specificity and sensitivity
2-8 week culture

31
Q

Describe the issues in public health. treatment and drug resistance

A

Category 3 pathogen- handled in corresponding lab- lab acquired infection

Prevent- early diagnosis and treatment

Treat- 2 months of 4 drugs
Rifampicin, Isoniazid, Pyrazinamide, Ethambutamol
Continue- 4 mths of R and I
- Resistance suspected- 5 drugs initially

32
Q

What would be classed as drug resistance in TB

A

Extensively drug resistance -> tuberculosis that is resistant to Rifampincin, isoniazid and to any quinolone and at least one second line anti TB agent